Polynovo Ltd (ASX:PNV) is an Australian medical device company that designs, develops, and manufactures dermal regeneration solutions using its patented NovoSorb biodegradable polymer technology.
After a difficult 2021, the Polynovo Ltd (ASX: PNV) share price has bounced 13% this morning after the company provided a sales update.
The S&P/ASX 200 (ASX: XJO) finished the week on a stronger note on Friday as Zip Co (ASX:Z1P) and Link (ASX:LNK) shares made headlines.
Medical device business Polynovo Ltd (ASX: PNV) share price has fallen 6% to end the week after announcing the resignation of its CEO.
Shares in PolyNovo Limited (ASX: PNV) sunk 5.6% on Friday following a resignation announcement. Here are the details.
The PolyNovo Ltd (ASX: PNV) share price struggled today, falling more than 4% as investors got their hands on the company’s FY21 results.
If you’re on the hunt for ASX growth shares, here are three I think are worth having on your watchlist: PNV, IFT & TYR
Shares in Polynovo Ltd (ASX: PNV) have been on a bit of a rollercoaster recently and are down 20% in the last six weeks. Is it time to buy?
This morning, medical device developer Avita Medical Inc (ASX: AVH) released its Q3 FY21 results to the market. Here’s what happened.
Medical device manufacturer PolyNovo Ltd (ASX: PNV) has had an impressive run recently, with its share price up nearly 30% in just two weeks. Here’s my take.
